心肌梗死溶栓治疗

Thrombolysis therapy for myocardial infarction

以上为机器翻译结果，快速获取精准的人工翻译结果，建议选择有道人工翻译

1
TIMI
比较3组相关导联再灌注心律失常发生率、ST段回落率、校正心肌梗死溶栓治疗（TIMI）帧数（CTFC）、肌酸激酶同工酶（CK-MB）峰值、左室射血分数（LVEF）的变化，并随访不良事件的发生情况。
2
thrombolysis in myocardial infarction
结果:替罗非班组于术前应用盐酸替罗非班使PCI前梗死相关血管心肌梗死溶栓治疗(thrombolysis in myocardial infarction,TIMI)血流分级提高,替罗非班组达1级、2级血流者比例分别高于对照组(均P<0·01),对照组完全闭塞比率明...

短语

1
目的：评价国产尿激酶在急性心肌梗死溶栓治疗中的有效性和安全性。
Objective: To study the efficacy and safety with thrombolysis of urokinase produced in China on acute myocardial infarction.
2
目的探讨在急诊科静脉溶栓治疗急性心肌梗死(ami)患者的临床效果及安全性。
Objective To study clinical efficacy of thrombolytic therapy in Emergency Department for acute myocardial infarction (AMI).
3
应用门电路平衡法心血池显像，对急性心肌梗死经尿激酶静脉溶栓治疗患者测定其左心室功能。
We evaluated the left ventricular function of acute myocardial infarction patients given thrombolytic therapy with urokinase by multiple gated equilibrium cardiac blood pool imaging.

点击反馈